Dual antithrombotic regimen after placement of coronary stents;Duale antiaggregatorische therapie nach implantation von koronarstents

Deutsche Medizinische Wochenschrift

Volumn 131, Issue 19, 2006, Pages 1105-1110

  Schneider, H ^a   Weber, F ^a   Holzhausen, C ^a   Korber T ^a   Ince, H ^a   Rehders, T ^a   Nienaber, C A ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; CLOPIDOGREL; TICLOPIDINE; ANTITHROMBOCYTIC AGENT; DRUG DERIVATIVE;

CORONARY ARTERY THROMBOSIS; CORONARY STENT; DOSE RESPONSE; HUMAN; REVIEW; CORONARY ARTERY OBSTRUCTION; DRUG POTENTIATION; STENT; THROMBOSIS; TIME; TREATMENT OUTCOME;

ASPIRIN; CORONARY STENOSIS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; HUMANS; PLATELET AGGREGATION INHIBITORS; STENTS; THROMBOSIS; TICLOPIDINE; TIME FACTORS; TREATMENT OUTCOME;

EID: 33744980468     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-941730     Document Type: Review

References (31)

1. ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery. Circulation 2002; 105: 1257-1267
2. Batchalor WB, Mahaffay KW, Berger PB et al. A randomised, plazebo-controlled trial of enoxiparin after high-risk coronary stenting: the ATLAST trial. J Am Coll Cardiol 2001; 38: 1608-1613
3. Bertrand MB, Legrand V, Boland J et al. Randomized multicenter comparison of conventional anticoagulation versus antiplatelet therapy in unplanned and elective coronary stenting. The Full Anticoagulation Versus Asprin and Ticlopidin (FANTASTIC) Study. Circulation 1996;98:1597-1603
4. Bertrand ME, Rupprecht HJ, Urban P et al. for the CLASSICS Investigators. Double-blind study of the safety of clopidogrel with and without a loading dose in combination with aspirin compared with ticlopidine in combination with aspirin after coronary stenting: The Clopidogrel Aspirin Stent International Cooperative Study (CLASSICS). Circulation 2000; 102: 624-629
5. Burger W, Chemnitius JM, Kneissl GD et al. Low-dose aspirin for secondary cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation-rewiev and meta-analysis. J Inten Med 2005; 257: 399-414
6. Cleland JG, Findlay I, Jafri S et al. The Warfarin/Aspirin Study in Heart Failure (WASH): a randomized trial comparing antithrobotic strategies for patients with heart failure. Am Heart J 2004; 148: 157-164
7. Cremers B, Maack C, Böhm M. Präoperative kardiovaskuläre Risikoeinschätzung - Therapie. Dtsch Med Wochenschr 2004; 129: 1260-1264
8. Douketis JD, Johnson JA, Turpie AG. Low-molecular-weight heparin as bridging anticoagulation during interruption of warfarin: Assesment of a standardized periprocedural anticoagulation regimen. Arch Intern Med 2004; 164: 1319-1326
9. fox KAA, Mehta SR, Peters R et al. Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-Elevation acute coronary syndrome: The Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial. Circulation 2004; 110: 1202-1208
10. Gawaz M. Das Blutplättchen: Physiologie, Pathophysiologie, Membranrezeptoren, antithrombozytäre Wirkstoffe und antithrombozytäre Therapie bei koronarer Herzerkrankung. 1. Auflage (Hrsg). Georg Thieme Verlag, 1999: 54-63
11. Iakovou I, Schmidt T, Bonizzoni E et al. Incidence, predictors, and outcome of thrombosis after succesful implantation of drug-eluting stems. JAMA 2005; 293: 2126-2130
12. Hamm CW, Arntz HR, Bode C et al. Leitlinien: Akutes Koronarsyndrom (ACS) Teil 1: Akutes Koronarsyndrom ohne persistierende ST-Hebung. Z Kardiol 2004;93:72-90
13. Kaluza GL, Joseph J, Lee JR et al. Catastrophic outcomes of noncardiac surgery soon after coronary stenting. J Am Coll Cardiol 2000; 36: 2351-2352
14. Leon MR, Baim DS, Popma JJ et al. The stent anticoagulation restenosis study investigators. A clinical trial comparing three antithrombotic-drug regimes after coronary-artery stenting. N Engl J Med 1998; 339: 1665-1671
15. Lorenzoni R, Lazzerini G, Cocci F et al. Short-term prevention of thromboembolic complications in patients with atrial fibrillation with aspirin plus clopidogrel: the Clopidogrel-Asprin Atrial Fibrillation (CLAAF) pilot study. Am Heart J 2004; 148: e6
16. Morcucci C, Chassot PG. Fatal myocardial infarction after lung resection in a patient with prophylactic preoperative coronary stenting. Br J Anaesth 2004; 5: 743-747
17. Massel D, Little SH. Risks and benefits of adding anti-platelet therapy to warfarin among patients with prosthetic heart valves: a meta-analysis. J Am Coll Cardiol 2001; 37: 569-578
18. Mehta SR, Yusuf F, Peters RJ et al. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet 2001; 358: 527-533
19. Moore M, Power M. Perioperative hemorrhage and combined clopidogrel and aspirin therapy. Anesthesiology 2004; 101: 792-794
20. Orford JL, Fasseas P, Melby S et al. Safety and efficacy of aspirin, clopidogrel, and warfarin after coronary stent placement in patients with an indication for anticoagulation. Am Heart J 2004; 147: 463-467
21. Patti G, Colonna G, Pasceri V et al. Randomized trial of high loading dose clopidogrel for reduction of periprocedural myocardial infarction in patients undergoing coronary intervention. Circulation 2005; 111: 2099-2106
22. Rubholi A, Colleta M, Sangiorgio P et al. Antithrombotic strategies in patients with an indication for long term anticoagulation undergoing coronary artery stenting: safety and efficacy data from a single center. Ital Heart J 2004; 5: 919-925
23. Schömig A, Neumann FJ, Kastrati A et al. A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents. N Engl J Med 1996; 334: 1084-1089
24. Sheldrake J. Drug eluting stent penetration in Europe. Cardiovasculare News 2004; 9: 20
25. Silber S, Albertsson P, Aviles FF. for the task Force of PCI of the European Society of Cardiology Guidelines for percutaneous coronary interventions. Eur Heart J 2005; 138: 804-847
26. Spencer A, Becker C. When guidelines collide... Am Heart J 2004; 147: 395-597
27. Steinhubl SR, Berger PB, Mann JT et al. Early and Sustained Dual Oral Antiplatelet Therapy Following Percutaneous Coronary Intervention (CREDO). JAMA 2002; 288: 2411-2420
28. Urban P, Macaya C, Rupprecht HJ et al. Randomized evaluation of anticoagulation versus antiplatelet therapy after coronary stent implantation in high-risk patients. The Multicenter Aspirin and Ticlopidin Trial after Intracoronary Stenting (MATTIS). Circulation 1998; 98: 2126-2132
29. Van Buren F, Mannebach H, Horstkotte D. 20. Bericht über die Leistungszahlen der Herzkatheterlabore in der Bundesrepublik Deutschland. Z Kardiol 2005; 942: 212-215
30. Wilson SH, Fasseas P, Orford JL et al. Clinical outcome of patients undergoing non-cardiac surgery in the two months following coronary Stenting. J Am Coll Cardiol 2004; 18: 713-714
31. Yusuf S, Zhao F, Mehta SR et al. The Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) trial programme: Effects of clopidogrel in addition of aspirin in patients with acute coronary sndromes without ST-elevation. N Engl J Med 2001; 345: 494-502